1 Exhibit 3.1 CONFIDENTIAL TREATMENT Note: Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Commission under Rule 24b-2. The omitted confidential material has been filed separately with the...Purchase Agreement • May 25th, 2000 • Basf Aktiengesellschaft /Fa/ • New York
DEFINITIONSConfidential Treatment • March 14th, 2001 • Basf Aktiengesellschaft • Chemicals & allied products • Illinois
DEPOSIT AGREEMENT Dated as of December 1, 1999 As Amended and Restated as of June 6, 2000 As Amended and Restated as of March 16, 2004Deposit Agreement • September 6th, 2007 • Basf Aktiengesellschaft • Chemicals & allied products • New York
DEPOSIT AGREEMENT, dated as of December 1, 1999, as amended and restated as of June 6, 2000, and as amended and restated as of March 16, 20042004, as further amended and restated as of ___________, 2007 among BASF AKTIENGESELLSCHAFT, a stock corporation organized and existing under the laws of the Federal Republic of Germany and its successors (the "Company"), THE BANK OF NEW YORK, a New York banking corporation and any successor as depositary hereunder (the "Depositary"), and all holders (including beneficial owners) from time to time of American Depositary ReceiptsShares (as hereinafter defined) issued hereunder.
andDeposit Agreement • May 25th, 2000 • Basf Aktiengesellschaft /Fa/ • New York
BASF Stock -------------------------------------------------------------------- ------------ Option ----------------------------------------------------------- --------------------- Program 2001Basf Stock • June 19th, 2001 • Basf Aktiengesellschaft • Chemicals & allied products
